About human protein c
Plasma-derived protein C replacement
Used for
- Treatment and prevention of serious blood clots in people with severe inherited protein C deficiency.
- Short-term prevention around surgery or childbirth in people with severe inherited deficiency.
Usual adult dose
Dose is individualized by body weight, protein C activity, and clinical response; given intravenously.
Usual dose in children
Dose is individualized by body weight, protein C activity, and clinical response; used in children, including newborns.
Common side effects
- Rash or itching
- Dizziness
- Fever
- Allergic reactions, including severe reactions
Important warnings
- Administer intravenously under medical supervision; monitor protein C activity and clotting.
- Severe allergic reactions can occur, especially in people with known protein C or mouse-protein sensitivity.
- Products made from human plasma carry a very small risk of infectious-agent transmission.
- Tell clinicians about other clot-prevention medicines; treatment may need close monitoring.
Pregnancy
May be used when clinically needed, including to prevent or treat dangerous clots; specialist supervision is required.
Breastfeeding
There is limited information; use requires a clinician’s assessment of benefits and risks.
Interactions
- Anticoagulants, including warfarin, may increase bleeding risk when used together.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.